1 Raturi A, "Where the endoplasmic reticulum and the mitochondrion tie the knot : the mitochondria-associated membrane(MAM)" 1833 : 213-224, 2013
2 Area-Gomez E, "Upregulated function of mitochondriaassociated ER membranes in Alzheimer disease" 31 : 4106-4123, 2012
3 Brand MD, "The sites and topology of mitochondrial superoxide production" 45 : 466-472, 2010
4 Lagouge M, "The role of mitochondrial DNA mutations and free radicals in disease and ageing" 273 : 529-543, 2013
5 McManus MJ, "The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease" 31 : 15703-15715, 2011
6 Franchi L, "The inflammasome : a caspase-1-activation platform that regulates immune responses and disease pathogenesis" 10 : 241-247, 2009
7 Mercer TR, "The human mitochondrial transcriptome" 146 : 645-658, 2011
8 López-Otín C, "The hallmarks of aging" 153 : 1194-1217, 2013
9 Finley LWS, "The coordination of nuclear and mitochondrial communication during aging and calorie restriction" 8 : 173-188, 2009
10 Subramanian N, "The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation" 153 : 348-361, 2013
11 Swerdlow RH, "The Alzheimer’s disease mitochondrial cascade hypothesis : progress and perspectives" 1842 : 1219-1231, 2013
12 Murphy MP, "Targeting antioxidants to mitochondria by conjugation to lipophilic cations" 47 : 629-656, 2007
13 Kukat C, "Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA" 108 : 13534-13539, 2011
14 Pickrell AM, "Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson’s disease" 31 : 17649-17658, 2011
15 Bacman SR, "Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs" 19 : 1111-1113, 2013
16 Anderson S, "Sequence and organization of the human mitochondrial genome" 290 : 457-465, 1981
17 Franchi L, "Sensing and reacting to microbes through the inflammasomes" 13 : 325-332, 2012
18 Ayala-Peña S., "Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis" 62 : 102-110, 2013
19 Nakamura T, "Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases" 18 : 1478-1486, 2011
20 Circu ML, "Reactive oxygen species, cellular redox systems, and apoptosis" 48 : 749-762, 2010
21 Liu W, "Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission" 108 : 12920-12924, 2011
22 Andreux Pa, "Pharmacological approaches to restore mitochondrial function" 12 : 465-483, 2013
23 Segref A, "Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system" 19 : 642-652, 2014
24 Mootha VK, "PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes" 34 : 267-273, 2003
25 Verfaillie T, "PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress" 19 : 1880-1891, 2012
26 Simmen T, "Oxidative protein folding in the endoplasmic reticulum : tight links to the mitochondria-associated membrane(MAM)" 1798 : 1465-1473, 2010
27 Warita H, "Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice" 89 : 147-152, 2001
28 Barsoum MJ, "Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons" 25 : 3900-3911, 2006
29 Hedskog L, "Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models" 110 : 7916-7921, 2013
30 Tonin Y, "Modelling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mtDNA" 289 : 13323-13334, 2014
31 Kurihara Y, "Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast" 287 : 3265-3272, 2012
32 Yun J, "Mitohormesis" 19 : 757-766, 2014
33 Gammage PA, "Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations" 6 : 1509-1639, 2014
34 Smith RaJ, "Mitochondrial pharmacology" 33 : 341-352, 2012
35 Westermann B, "Mitochondrial fusion and fission in cell life and death" 11 : 872-884, 2010
36 Knott AB, "Mitochondrial fragmentation in neurodegeneration" 9 : 505-518, 2008
37 Winklhofer KF, "Mitochondrial dysfunction in Parkinson’s disease" 1802 : 29-44, 2010
38 Lin MT, "Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases" 443 : 787-795, 2006
39 Suen D, "Mitochondrial dynamics and apoptosis" 1577-1590, 2008
40 Zhuang J, "Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity" 2 : 2-7, 2013
41 Yan MH, "Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease" 62 : 90-101, 2013
42 Gredilla R, "Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer’s disease" 33 : 694-707, 2012
43 Hirai K, "Mitochondrial abnormalities in Alzheimer’s disease" 21 : 3017-3023, 2001
44 Reeve AK, "Mitochondrial DNA mutations in disease, aging, and neurodegeneration" 1147 : 21-29, 2008
45 Krishnan KJ, "Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease" 33 : 2210-2214, 2012
46 Kraytsberg Y, "Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons" 38 : 518-520, 2006
47 Dhaliwal GK, "Mitochondrial DNA deletion mutation levels are elevated in ALS brains" 11 : 2507-2509, 2000
48 Siddiqui A, "Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease" 53 : 1478-1488, 2012
49 Manczak M, "Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer’s disease neurons" 20 (20): S609-S631, 2010
50 Jin H, "Mitochondria-targeted antioxidants for treatment of Parkinson’s disease : preclinical and clinical outcomes" 1842 : 1282-1294, 2013
51 Kim S-J, "Mitochondria-targeted Ogg1 and aconitase-2 prevent oxidant-induced mitochondrial DNA damage in alveolar epithelial cells" 289 : 6165-6176, 2014
52 Cha M-Y, "Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death" 7 : e34929-, 2012
53 Federico A, "Mitochondria, oxidative stress and neurodegeneration" 322 : 254-262, 2012
54 Readnower RD, "Mitochondria, amyloid β, and Alzheimer’s disease" 2011 : 104545-, 2011
55 Biswas G, "Mitochondria to nucleus stress signaling : a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta" 161 : 507-519, 2003
56 Okamoto K., "Mitochondria breathe for autophagy" 30 : 2095-2096, 2011
57 Green DR, "Mitochondria and the autophagyinflammation-cell death axis in organismal aging" 333 : 1109-1112, 2011
58 Dai D-F, "Mitochondria and cardiovascular aging" 110 : 1109-1124, 2012
59 Israelson A, "Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS" 67 : 575-587, 2010
60 Oxygen R, "Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation" 12 : 1431-1470, 2010
61 Brown GC, "Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria" 27 : 325-355, 2003
62 Kikuchi H, "Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis" 103 : 408-414, 2002
63 Sterky FH, "Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chaindeficient dopamine neurons in vivo" 108 : 12937-12942, 2011
64 Epstein CB, "Genome-wide responses to mitochondrial dysfunction" 12 : 297-308, 2001
65 Merz S, "Genome-wide deletion mutant analysis reveals genes required for respiratory growth, mitochondrial genome maintenance and mitochondrial protein synthesis in Saccharomyces cerevisiae" 10 : R95-, 2009
66 Spelbrink JN, "Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges" 62 : 19-32, 2010
67 Iwasawa R, "Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction" 30 : 556-568, 2011
68 Tufi R, "Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease" 16 : 157-166, 2014
69 Murakami T, "Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene" 1150 : 182-189, 2007
70 Wang J-Q, "Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease" 288 : 3070-3084, 2013
71 Gomes AP, "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging" 155 : 1624-1638, 2013
72 Oliveira JMa, "Could successful (mitochondrial) networking help prevent Huntington’s disease?" 2 : 487-489, 2010
73 Lezza AM, "Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles" 205 : 772-779, 1994
74 Heddi A, "Coordinate induction of energy gene expression in tissues of mitochondrial disease patients" 274 : 22968-22976, 1999
75 Rodriguez-Cuenca S, "Consequences of long-term oral administration of the mitochondriatargeted antioxidant MitoQ to wild-type mice" 48 : 161-172, 2010
76 Byun J, "CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer’s disease" 2014
77 Canugovi C, "Base excision DNA repair levels in mitochondrial lysates of Alzheimer’s disease" 35 : 1-8, 2014
78 Brooks C, "Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins" 104 : 11649-11654, 2007
79 Nakahira K, "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome" 12 : 222-230, 2011
80 Hamasaki M, "Autophagosomes form at ER-mitochondria contact sites" 495 : 389-393, 2013
81 Calkins MJ, "Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer’s disease mice : implications for impaired mitochondrial biogenesis and synaptic damage" 1812 : 1182-1189, 2011
82 Miquel J, "An update on the mitochondrial-DNA mutation hypothesis of cell aging" 275 : 209-216, 1992
83 Reddy PH, "Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease" 218 : 286-292, 2009
84 Lawlor KE, "Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria?" 1840 : 1433-1440, 2013
85 Wen H, "A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation?" 13 : 352-357, 2012